https://www.marketscreener.com/quote/stock/HUTCHISON-CHINA-MED-4006040/news/Hutchison-China-MediTech-Sulfatinib-clinical-results-and-fruquintinib-savolitinib-combination-prec-21342147/?utm_source=telegram&utm_medium=social&utm_campaign=share